According to Zacks, “Eisai Co LTD is involved in the Biotechnology and Drug Industry. Their principle activities are the manufacture and sale of pharmaceutical products. Operations are carried out through the following divisions: Pharmaceuticals: veterinary drugs other food additives, livestock feed and pharmaceutical production systems and equipment. The Group has overseas consolidated subsidiaries in the United States, Canada, the United Kingdom, France, Germany, East Southeast Asia and South and Central America. “
Eisai Co. (NASDAQ:ESALY) opened at 63.92 on Tuesday. Eisai Co. has a 52 week low of $53.55 and a 52 week high of $67.60. The firm’s 50-day moving average price is $61.72 and its 200 day moving average price is $60.45. The company has a market capitalization of $18.28 billion and a PE ratio of 26.95.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Eisai Co. Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eisai Co. Ltd and related companies with MarketBeat.com's FREE daily email newsletter.